Latest ""
As coronavirus deaths rise, but cases drop, VA defends continued use of controversial drug
More than 1,100 VA patients have died from the virus since early March.
More deaths, no benefit from malaria drug in VA virus study
A malaria drug widely touted by President Donald Trump for treating the new coronavirus showed no benefit in a large analysis of its use in U.S. veterans hospitals.
Evidence lacking to tie malaria drugs to PTSD-like symptoms and other long-term health issues, researchers say
A National Academy of Sciences panel has concluded there is not enough research to determine whether malaria preventives can cause permanent health problems.
By Patricia Kime
Results of scientific inquiry into malaria drugs used by US troops expected in March
Report could help veterans file disability claims with the VA.
By Patricia Kime
‘I plead with you to look at this very closely,’ retiree tells panel studying health effects of anti-malarial drugs
National Academy of Sciences, Engineering and Medicine is looking at scientific evidence related to long-term effects of anti-malarials, particularly mefloquine.
By Karen Jowers
Military scientists have discovered a new malaria drug that could help eradicate the disease — and it’s hitting shelves soon
It's the first malaria preventive drug approved in over 18 years.
By Karen Jowers